Cargando…
Cardiac Complications Associated with COVID-19, MIS-C, and mRNA COVID-19 Vaccination
The COVID-19 vaccine is now approved for individuals greater than 5 years of age, but vaccination rates remain lower than expected in the pediatric age group. Misinformation and widespread reporting of vaccine-related myocarditis are contributing to vaccine hesitancy. When compared to severe cardiac...
Autores principales: | Chin, Stephanie E., Bhavsar, Sejal M., Corson, Andrew, Ghersin, Zelda J., Kim, Hannah S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902276/ https://www.ncbi.nlm.nih.gov/pubmed/35258639 http://dx.doi.org/10.1007/s00246-022-02851-x |
Ejemplares similares
-
Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination
por: Wangu, Zoon, et al.
Publicado: (2022) -
Multisystem Inflammatory Syndrome in Children (MIS-C), Possibly Due to COVID-19 mRNA Vaccination
por: Keka-Sylaj, Alije, et al.
Publicado: (2023) -
No evidence of an increased risk for cardiac complications following mRNA COVID-19 vaccines
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2023) -
No evidence of an increased risk for cardiac complications following mRNA COVID-19 vaccines
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2023) -
Reply to Letter to the Editor Regarding: “Myocarditis and Cardiac Complications Associated With COVID-19 and mRNA Vaccination”
por: Holland, David J., et al.
Publicado: (2022)